Cargando…
Human urinary kallidinogenase may improve the prognosis of acute stroke patients with early neurological deterioration
OBJECTIVES: Some acute ischemic stroke (AIS) patients still suffer from early neurological deterioration (END) after receiving intravenous thrombolysis (IVT), and these patients often have a poor prognosis. The purpose of our study is to observe the efficacy and safety of human urinary kallidinogena...
Autores principales: | Xie, Yiju, Li, Shengyu, Zhang, Jian, Chen, Shijian, Deng, Xuhui, Cen, Gengyu, Liang, Zhijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933782/ https://www.ncbi.nlm.nih.gov/pubmed/35152571 http://dx.doi.org/10.1002/brb3.2524 |
Ejemplares similares
-
Exogenous human urinary kallidinogenase increases cerebral blood flow in patients with acute ischemic stroke
por: Miao, Jing, et al.
Publicado: (2016) -
Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke
por: Han, Lijuan, et al.
Publicado: (2015) -
Urinary kallidinogenase for the treatment of cerebral arterial stenosis
por: Zhao, Liandong, et al.
Publicado: (2015) -
Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
por: Qian, Yun, et al.
Publicado: (2019) -
Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases
por: Wei, Zhenyu, et al.
Publicado: (2018)